Kontafarma China Holdings Files Updated Director List with HKEX

Reuters

2025/11/14

Kontafarma China Holdings Files Updated Director List with HKEX

Kontafarma China Holdings Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange, effective 14 November 2025. The Board comprises Executive Directors Wang Feifei (Chairman and President), Guo Zixiu (Financial Controller), and Liu Jiankun; Non-Executive Director Huang Yu; and Independent Non-Executive Directors Tang Lai Wah, Ho Ho Ming, and Yao Xiaomin. Regarding committee memberships: Wang Feifei serves as Chairman of the Executive, Nomination, Share Dealing, and Investment Committees. Guo Zixiu is a member of the Executive, Risks Management, and Share Dealing Committees. Liu Jiankun is also a member of the Executive and Share Dealing Committees. Among Independent Non-Executive Directors, Tang Lai Wah chairs the Audit Committee and is a member of the Remuneration, Nomination, and Investment Committees. Ho Ho Ming is Chairman of the Risks Management Committee and a member of the Audit and Investment Committees. Yao Xiaomin chairs the Remuneration Committee and is a member of the Audit and Nomination Committees.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kontafarma China Holdings Ltd. published the original content used to generate this news brief on November 14, 2025, and is solely responsible for the information contained therein.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2583488505"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2583488505\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2583488505?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-14 20:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2583488505","market":"fut","top_or_hot":-1,"title":"Kontafarma China Holdings Files Updated Director List with HKEX","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Kontafarma China Holdings Files Updated Director List with HKEX\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Kontafarma China Holdings Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange, effective 14 November 2025. The Board comprises Executive Directors Wang Feifei (Chairman and President), Guo Zixiu (Financial Controller), and Liu Jiankun; Non-Executive Director Huang Yu; and Independent Non-Executive Directors Tang Lai Wah, Ho Ho Ming, and Yao Xiaomin. Regarding committee memberships: Wang Feifei serves as Chairman of the Executive, Nomination, Share Dealing, and Investment Committees. Guo Zixiu is a member of the Executive, Risks Management, and Share Dealing Committees. Liu Jiankun is also a member of the Executive and Share Dealing Committees. Among Independent Non-Executive Directors, Tang Lai Wah chairs the Audit Committee and is a member of the Remuneration, Nomination, and Investment Committees. Ho Ho Ming is Chairman of the Risks Management Committee and a member of the Audit and Investment Committees. Yao Xiaomin chairs the Remuneration Committee and is a member of the Audit and Nomination Committees.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kontafarma China Holdings Ltd. published the original content used to generate this news brief on November 14, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kontafarma China Holdings Files Updated Director List with HKEX</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKontafarma China Holdings Files Updated Director List with HKEX\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-11-14 20:39</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Kontafarma China Holdings Files Updated Director List with HKEX\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Kontafarma China Holdings Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange, effective 14 November 2025. The Board comprises Executive Directors Wang Feifei (Chairman and President), Guo Zixiu (Financial Controller), and Liu Jiankun; Non-Executive Director Huang Yu; and Independent Non-Executive Directors Tang Lai Wah, Ho Ho Ming, and Yao Xiaomin. Regarding committee memberships: Wang Feifei serves as Chairman of the Executive, Nomination, Share Dealing, and Investment Committees. Guo Zixiu is a member of the Executive, Risks Management, and Share Dealing Committees. Liu Jiankun is also a member of the Executive and Share Dealing Committees. Among Independent Non-Executive Directors, Tang Lai Wah chairs the Audit Committee and is a member of the Remuneration, Nomination, and Investment Committees. Ho Ho Ming is Chairman of the Risks Management Committee and a member of the Audit and Investment Committees. Yao Xiaomin chairs the Remuneration Committee and is a member of the Audit and Nomination Committees.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kontafarma China Holdings Ltd. published the original content used to generate this news brief on November 14, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01312","symbol_name":"華控康泰","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDLbjtGpD:1","article_id":"2583488505","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2583488505","pubTimestamp":1763123999,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Kontafarma China Holdings Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange, effective 14 November 2025. The Board comprises Executive Directors Wang Feifei , Guo Zixiu , and Liu Jiankun; Non-Executive Director Huang Yu; and Independent Non-Executive Directors Tang Lai Wah, Ho Ho Ming, and Yao Xiaomin. Regarding committee memberships: Wang Feifei serves as Chairman of the Executive, Nomination, Share Dealing, and Investment Committees. Guo Zixiu is a member of the Executive, Risks Management, and Share Dealing Committees. Liu Jiankun is also a member of the Executive and Share Dealing Committees. Among Independent Non-Executive Directors, Tang Lai Wah chairs the Audit Committee and is a member of the Remuneration, Nomination, and Investment Committees. Ho Ho Ming is Chairman of the Risks Management Committee and a member of the Audit and Investment Committees. Yao Xiaomin chairs the Remuneration Committee and is a member of the Audit and Nomi","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01312":"华控康泰","BK1191":"制药"},"translate_title":"Kontafarma China Holdings向香港交易所提交最新董事名单","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01312":0.9},"content_text":"Kontafarma China Holdings Files Updated Director List with HKEX\n    \n\n        Kontafarma China Holdings Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange, effective 14 November 2025. The Board comprises Executive Directors Wang Feifei (Chairman and President), Guo Zixiu (Financial Controller), and Liu Jiankun; Non-Executive Director Huang Yu; and Independent Non-Executive Directors Tang Lai Wah, Ho Ho Ming, and Yao Xiaomin. Regarding committee memberships: Wang Feifei serves as Chairman of the Executive, Nomination, Share Dealing, and Investment Committees. Guo Zixiu is a member of the Executive, Risks Management, and Share Dealing Committees. Liu Jiankun is also a member of the Executive and Share Dealing Committees. Among Independent Non-Executive Directors, Tang Lai Wah chairs the Audit Committee and is a member of the Remuneration, Nomination, and Investment Committees. Ho Ho Ming is Chairman of the Risks Management Committee and a member of the Audit and Investment Committees. Yao Xiaomin chairs the Remuneration Committee and is a member of the Audit and Nomination Committees.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kontafarma China Holdings Ltd. published the original content used to generate this news brief on November 14, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}